STERIS plc (Ireland) Ordinary Shares (STE): Price and Financial Metrics
STERIS plc (Ireland) Ordinary Shares (STE)
Today's Latest Price: $154.22 USD
Updated Aug 7 12:00am
Add STE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
STE Stock Summary
- With a market capitalization of $13,417,092,190, STERIS plc has a greater market value than 87.88% of US stocks.
- STERIS plc's stock had its IPO on November 3, 2015, making it an older stock than just 16.23% of US equities in our set.
- The volatility of STERIS plc's share price is greater than that of only 1.6% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to STERIS plc, a group of peers worth examining would be CMD, MSON, KAI, JCOM, and NVT.
- STE's SEC filings can be seen here. And to visit STERIS plc's official web site, go to www.steris.com.
STE Stock Price Chart Technical Analysis Charts
STE Price/Volume Stats
| Current price | $154.22 | 52-week high | $168.98 |
| Prev. close | $155.98 | 52-week low | $105.69 |
| Day low | $152.37 | Volume | 498,600 |
| Day high | $157.14 | Avg. volume | 659,311 |
| 50-day MA | $156.26 | Dividend yield | 0.96% |
| 200-day MA | $151.05 | Market Cap | 13.10B |
STERIS plc (Ireland) Ordinary Shares (STE) Company Bio
Steris Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The company was founded in 1985 and is based in Mentor, Ohio.
STE Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $154.22 | $153.67 | -3% |
We started the process of determining a valid price forecast for STERIS plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that STERIS plc ranked in the 47th percentile in terms of potential gain offered. As for the metrics that stood out in our discounted cash flow analysis of STERIS plc, consider:
- Interest coverage, a measure of earnings relative to interest payments, is 13.38; that's higher than 77.03% of US stocks in the Healthcare sector that have positive free cash flow.
- The business' balance sheet suggests that 9% of the company's capital is sourced from debt; this is greater than merely 21.2% of the free cash flow producing stocks we're observing.
- STE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 39.23% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -4% |
| 1% | -3% |
| 2% | -3% |
| 3% | -2% |
| 4% | -1% |
| 5% | 0% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as STE, try HRC, CNC, MEDP, DXCM, and AMGN.
Loading social stream, please wait...